“…The pace at which VV‐ECMO technology is improving, together with advances in our understanding of patient care, may limit the utility of past research as a means to prognosticate for patients of the future . With regards to the future, it is likely that improvements will continue, demand will increase, there will be a need for more SRFCs and VV‐ECMO may become more widely available in the UK . Our understanding of decision‐making for such patients must keep with the pace of these advances.…”